Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


US Congress Roundup: Senators Reject COVID-19 Relief Plan; Lawmakers Fault Verma Promos

House Energy and Commerce Committee also passes bill that increases oxygen equipment payments, as Congress gets back to work

Executive Summary

Upon US lawmakers’ return from an August recess, senators wrangle over an acceptable coronavirus relief package, while the House finalizes medtech bills and probes Medicare chief Seema Verma’s expenses.

You may also be interested in...

US Government Awards $481M To Help Cue Health Expand COVID-19 Test Production

Cue’s point-of-care molecular test earned an FDA emergency use authorization in June.

Bill Advances Mandating Private Insurance Coverage Of Devices To Correct Birth Defects

Proposed legislation that would require private insurers to cover devices to correct cleft palate, congenital cataracts and other birth defects advanced in the US House on 9 September.

Senate GOP Coughs Up Only $16Bn For COVID-19 Testing In ‘Emaciated’ Relief Package

The US Senate will vote Thursday on its slimmed-down coronavirus pandemic relief package, Senate Majority Leader Mitch McConnell says.

Related Content





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts